Business
SS Innovations Reports Second Quarter 2025 Financial Results
Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and
About this update from Ss Innovations International Inc.
[{"type":"text","content":"Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth FORT LAUDERDALE, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and six months ended June 30, 2025. The Company also filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, with the Securities and Exchange Commission on August 6, 2025. Second Quarter 2025 Overview Revenue increased 121.8% to $10.0 million from $4.5 million in the second quarter of 2024.Gross margin expanded to 59.1% from 31.9% in the second quarter of 2024.Gross profit rose 311.4% to $5.9 million from $1.4 million in the second quarter of 2024.Net loss of $0.3 million, or $(0.00) per diluted share, compared to a net loss of $4.1 million, or $(0.02) per diluted share, in the second quarter of 2024.SSi Mantra surgical robotic system installations totaled 23, up 130% from 10 installations in the second quarter of 2024 and up 53% from 15 installations in the first quarter of 2025. First Half 2025 Overview Revenue increased 85.6% to $15.1 million from $8.1 million in the first half of 2024.Gross margin expanded to 46.3% from 26.6% in the first half of 2024.Gross profit rose 223.3% to $7.0 million from $2.2 million in the first half of 2024.Net loss of $5.9 million, or $(0.03) per diluted share, compared to net loss of $14.0 million, or $(0.08) per diluted share, in the first half of 2024.SSi Mantra surgical robotic system installations totaled 38, up 100% from 19 installations in the first half of 2024. As of June 30, 2025 Long-term debt of $0.Cash and cash equivalents totaled $11.4 million, excluding restricted cash. SSi Mantra cumulative installed base totaled 105 in seven countries and cumulative surgeries reached 4,657. CEO Commentary Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We continue to execute on our strategic initiatives and delivered strong revenue growth in the second quarter of 2025, driven by higher unit sales of our advanced, cost-e...